Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Hisashige Kanbara"'
Autor:
Satomi Yagi, Yasuhiro Koh, Hiroaki Akamatsu, Kuninobu Kanai, Atsushi Hayata, Nahomi Tokudome, Keiichiro Akamatsu, Katsuya Endo, Seita Nakamura, Masayuki Higuchi, Hisashige Kanbara, Masanori Nakanishi, Hiroki Ueda, Nobuyuki Yamamoto
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179744 (2017)
Circulating tumor cells (CTCs), defined as tumor cells circulating in the peripheral blood of patients with solid tumors, are relatively rare. Diagnosis using CTCs is expected to help in the decision-making for precision cancer medicine. We have deve
Externí odkaz:
https://doaj.org/article/9cf28ee5e7b1459cbef8ed0437b545d4
Autor:
Masahito Hosokawa, Hirotsugu Kenmotsu, Yasuhiro Koh, Tomoko Yoshino, Takayuki Yoshikawa, Tateaki Naito, Toshiaki Takahashi, Haruyasu Murakami, Yukiko Nakamura, Asuka Tsuya, Takehito Shukuya, Akira Ono, Hiroaki Akamatsu, Reiko Watanabe, Sachiyo Ono, Keita Mori, Hisashige Kanbara, Ken Yamaguchi, Tsuyoshi Tanaka, Tadashi Matsunaga, Nobuyuki Yamamoto
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e67466 (2013)
Epithelial cell adhesion molecule (EpCAM)-based enumeration of circulating tumor cells (CTC) has prognostic value in patients with solid tumors, such as advanced breast, colon, and prostate cancer. However, poor sensitivity has been reported for non-
Externí odkaz:
https://doaj.org/article/8db1a62b62d948e49f6cf32d474d7fa1
Autor:
Nakamura Seita, Shinsuke Kitazawa, Hideo Ichimura, Katsuya Endo, Yukio Sato, Yusuke Yamamoto, Takeshi Nawa, Keisuke Kobayashi, Kei Shimizu, Matsunaga Tatsuya, Satomi Yagi, Hisashige Kanbara, Taihei Odagiri
We have developed a metallic micro-cavity array filter and an automated detection system for capturing circulating tumor cells (CTCs). In this single institutional pilot study, we assessed the ability of this device to detect CTCs in patients with lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ee7a32bf5195329c461f6ffa3856b33
https://europepmc.org/articles/PMC7016515/
https://europepmc.org/articles/PMC7016515/
Autor:
Kuninobu Kanai, Nahomi Tokudome, Satomi Yagi, Hiroki Ueda, Atsushi Hayata, Keiichiro Akamatsu, Masayuki Higuchi, Yasuhiro Koh, Masanori Nakanishi, Nobuyuki Yamamoto, Hiroaki Akamatsu, Hisashige Kanbara
Publikováno v:
Clinical lung cancer. 20(4)
Background Blockade of the programmed death receptor-1 (PD-1) pathway is effective against solid tumors including lung cancer. PD-ligand 1 (PD-L1) expression on tumor tissue serves as a predictive biomarker for the efficacy of PD-1 pathway blockade.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00806fc63fd08bf703b94064959bff6a
https://pubmed.ncbi.nlm.nih.gov/31005568
https://pubmed.ncbi.nlm.nih.gov/31005568
Autor:
Masafumi Kanetomo, Yoshihito Kikuhara, Ryo Negishi, Nakamura Seita, Tadashi Matsunaga, Masahito Hosokawa, Tsuyoshi Tanaka, Hisashige Kanbara, Tomoko Yoshino
Publikováno v:
Biosensors and Bioelectronics. 67:438-442
Circulating tumor cells (CTCs) are well recognized as useful biomarker for cancer diagnosis and potential target of drug discovery for metastatic cancer. Efficient and precise recovery of extremely low concentrations of CTCs from blood has been requi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::935a87b8c57e7113c0890c47b624c8aa
https://doi.org/10.1016/j.bios.2014.09.002
https://doi.org/10.1016/j.bios.2014.09.002
Autor:
Keiichiro Akamatsu, Hisashige Kanbara, Hiroki Ueda, Nahomi Tokudome, Satomi Yagi, Masayuki Higuchi, Yasuhiro Koh, Kuninobu Kanai, Nobuyuki Yamamoto, Atsushi Hayata, Hiroaki Akamatsu, Masanori Nakanishi, Nakamura Seita, Katsuya Endo
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 6, p e0179744 (2017)
PLoS ONE, Vol 12, Iss 6, p e0179744 (2017)
Circulating tumor cells (CTCs), defined as tumor cells circulating in the peripheral blood of patients with solid tumors, are relatively rare. Diagnosis using CTCs is expected to help in the decision-making for precision cancer medicine. We have deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4778b03f7531e15344e3980b0f5c8ed3
http://europepmc.org/articles/PMC5480994
http://europepmc.org/articles/PMC5480994
Autor:
Yasuhiro Koh, Hisashige Kanbara, Nobuyuki Yamamoto, Tomoko Yoshino, Yoshihito Kikuhara, Hirotsugu Kenmotsu, Toshiaki Takahashi, Tateaki Naito, Takayuki Yoshikawa, Masahito Hosokawa, Tsuyoshi Tanaka, Ryo Negishi, Ken Yamaguchi, Tadashi Matsunaga
Publikováno v:
Analytical Chemistry. 85:5692-5698
In this study, we present a method for efficient enrichment of small-sized circulating tumor cells (CTCs) such as those found in the blood of small-cell lung cancer (SCLC) patients using a microcavity array (MCA) system. To enrich CTCs from whole blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7f9550cb8ffaf792c4afa9cb149244
https://doi.org/10.1021/ac400167x
https://doi.org/10.1021/ac400167x
Autor:
Kaori Takai, Tomoko Yoshino, Hisashige Kanbara, Tadashi Matsunaga, Tsuyoshi Tanaka, Ryo Negishi
Publikováno v:
2016 World Automation Congress (WAC).
Circulating tumor cells (CTCs) are defined as tumor cells circulating in the peripheral blood of patients with metastatic cancer. CTCs are well recognized as accessible and valuable biomarkers for cancer diagnosis and are a potential target for drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fe07ae3f8497a4d97140a5edea6179a
https://doi.org/10.1109/wac.2016.7583055
https://doi.org/10.1109/wac.2016.7583055
Autor:
Masanori Nakanishi, Satomi Yagi, Keiichiro Akamatsu, Hisashige Kanbara, Nahomi Tokudome, Hiroki Ueda, Hiroaki Akamatsu, Nobuyuki Yamamoto, Yasuhiro Koh, Ayaka Tanaka, Kuninobu Kanai, Masayuki Higuchi, Atsushi Hayata
Publikováno v:
Journal of Thoracic Oncology. 12:S822-S823
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8e624d53a4fb72ed561e8e6329f4d7a
https://doi.org/10.1016/j.jtho.2016.11.1112
https://doi.org/10.1016/j.jtho.2016.11.1112
Autor:
Hiroki Ueda, Nobuyuki Yamamoto, Masanori Nakanishi, Keita Mori, Masayuki Higuchi, Hisashige Kanbara, Keiichiro Akamatsu, Hiroaki Akamatsu, Nahomi Tokudome, Yasuhiro Koh, Kuninobu Kanai, Atsushi Hayata
Publikováno v:
Molecular Cancer Therapeutics. 17:A056-A056
Background: Nivolumab (anti-PD-1 antibody) has become a new standard treatment in pretreated, advanced non-small cell lung cancer (NSCLC). Although strong expression of PD-L1 on tumor tissue has predictive value, significance of its expression on cir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75187029bd493bfe838e586c055773ec
https://doi.org/10.1158/1535-7163.targ-17-a056
https://doi.org/10.1158/1535-7163.targ-17-a056